Neutrophil extracellular traps mediate the crosstalk between plaque microenvironment and unstable carotid plaque formation

The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironm...

Full description

Saved in:
Bibliographic Details
Published inExperimental & molecular medicine Vol. 56; no. 8; pp. 1717 - 1735
Main Authors Cao, Yu, Chen, Minghui, Jiao, Xinyu, Li, Shuijie, Wang, Dong, Zhan, Yongxuan, Li, Jiaju, Hao, Zhongfei, Li, Qingbin, Liu, Yang, Feng, Yan, Li, Ruiyan, Wang, Hongjun, Liu, Mingli, Fu, Qiang, Li, Yongli
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2024
Springer Nature B.V
Nature Publishing Group
생화학분자생물학회
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86 )-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 ( LY86 ), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. NETs influence carotid plaque microenvironment and neovascularization Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
AbstractList The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.
Abstract The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. KCI Citation Count: 4
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.NETs influence carotid plaque microenvironment and neovascularizationAtherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86 )-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 ( LY86 ), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. NETs influence carotid plaque microenvironment and neovascularization Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86 )-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 ( LY86 ), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
Author Li, Shuijie
Hao, Zhongfei
Li, Jiaju
Zhan, Yongxuan
Feng, Yan
Wang, Dong
Liu, Yang
Fu, Qiang
Li, Qingbin
Li, Yongli
Wang, Hongjun
Chen, Minghui
Li, Ruiyan
Liu, Mingli
Cao, Yu
Jiao, Xinyu
Author_xml – sequence: 1
  givenname: Yu
  surname: Cao
  fullname: Cao, Yu
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 2
  givenname: Minghui
  surname: Chen
  fullname: Chen, Minghui
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 3
  givenname: Xinyu
  surname: Jiao
  fullname: Jiao, Xinyu
  organization: Department of Ultrasound, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
– sequence: 4
  givenname: Shuijie
  surname: Li
  fullname: Li, Shuijie
  organization: Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)
– sequence: 5
  givenname: Dong
  surname: Wang
  fullname: Wang, Dong
  organization: Scientific Research Centre, The Second Affiliated Hospital of Harbin Medical University
– sequence: 6
  givenname: Yongxuan
  surname: Zhan
  fullname: Zhan, Yongxuan
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 7
  givenname: Jiaju
  surname: Li
  fullname: Li, Jiaju
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 8
  givenname: Zhongfei
  surname: Hao
  fullname: Hao, Zhongfei
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 9
  givenname: Qingbin
  surname: Li
  fullname: Li, Qingbin
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 10
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 11
  givenname: Yan
  surname: Feng
  fullname: Feng, Yan
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 12
  givenname: Ruiyan
  surname: Li
  fullname: Li, Ruiyan
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 13
  givenname: Hongjun
  surname: Wang
  fullname: Wang, Hongjun
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 14
  givenname: Mingli
  surname: Liu
  fullname: Liu, Mingli
  email: slester@yeah.net
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
– sequence: 15
  givenname: Qiang
  surname: Fu
  fullname: Fu, Qiang
  email: fuqiang19890105@163.com
  organization: Department of Chinese Formulae, Heilongjiang University of Chinese Medicine
– sequence: 16
  givenname: Yongli
  surname: Li
  fullname: Li, Yongli
  email: liyongli9999@163.com
  organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39085350$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003114952$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kktv1DAUhSNURB_wB1igSGwQUsCPPJwVqioeI1UgobK27Ph6xlPHHmynPH49nqQtbRfNxpb9nZPre89xceC8g6J4idE7jCh7HzEhXVshUlcIE4ar-klxRFBPqrbG9ODO_rA4jnGLEGnqrn5WHNIesYY26Kj4-xWmFPxuY2wJv1MQA1g7WRHKvN_FcgRlRIIybaAcgo8xCXtZSki_AFy5s-LnBOVo8hW4KxO8G8GlUjhVTi6z0maZCD4ZdQNrH0aRjHfPi6da2AgvrteT4senjxdnX6rzb59XZ6fn1dB0baowk61sBFVSKoqVUICl7hXWRKoWAWZd08haUI2oaBXTuCegyLA_oVj2lJ4UbxdfFzS_HAz3wszr2vPLwE-_X6w4Ri2mTY8zvFpg5cWW74IZRfgzK-YDH9ZchGQGC7xRUAupRN-1qmZCMlYjpFivpaZKsy57fVi8dpPMfRxyZ4Kw90zv3zizyUVdcYxpl2fXZIc31w7B597FxEcT9xMSDvwUOUWs7Zv89Rl9_QDd-im43FhOMUL5cR2tM_Xqbkm3tdwEIgNkAeZhB9C3CEZ8nzq-pI7n1PE5dXzvyh6IBpPmGednGfu4lC7SmP_j1hD-l_2I6h-K9u9X
CitedBy_id crossref_primary_10_3389_fendo_2024_1434580
crossref_primary_10_1111_jcmm_70220
crossref_primary_10_1016_j_compbiomed_2025_109844
Cites_doi 10.3858/emm.2008.40.3.332
10.3791/52687
10.1160/TH11-09-0650
10.1093/eurheartj/ehu041
10.1007/s10495-013-0873-z
10.1161/CIRCULATIONAHA.109.866053
10.1016/j.biopha.2022.114000
10.1096/fj.07-094235
10.1161/ATVBAHA.108.179739
10.1161/ATVBAHA.110.211342
10.1016/j.ajhg.2019.03.004
10.1172/JCI84538
10.1161/01.CIR.0000087480.94275.97
10.3390/ijms22020978
10.4049/jimmunol.173.6.3653
10.1097/HCO.0000000000000226
10.1002/jnr.21565
10.5966/sctm.2014-0097
10.4049/jimmunol.1400586
10.4049/jimmunol.161.3.1348
10.1111/j.1744-313X.2007.00711.x
10.1093/eurheartj/ehv044
10.1007/s10741-019-09881-3
10.1038/nri3898
10.1016/j.biomaterials.2011.07.006
10.1161/01.CIR.0000144307.82502.32
10.1189/jlb.1209822
10.1038/ni.1628
10.1038/ni755
10.1161/CIRCRESAHA.116.309692
10.1080/07853890802186913
10.1161/CIRCULATIONAHA.106.652859
10.1038/s42003-019-0662-5
10.1016/S0021-9150(02)00018-7
10.1111/j.1749-6632.1997.tb52011.x
10.1016/j.rvsc.2017.02.026
10.1038/35025203
10.1016/j.jmb.2011.09.020
10.1016/j.intimp.2020.106902
10.1016/j.cell.2020.01.015
10.1182/blood-2014-03-453217
10.1038/ni1198
10.1073/pnas.1004153107
ContentType Journal Article
Copyright The Author(s) 2024 corrected publication 2025
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024 corrected publication 2025
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
ACYCR
DOI 10.1038/s12276-024-01281-4
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef


Publicly Available Content Database

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 2092-6413
EndPage 1735
ExternalDocumentID oai_kci_go_kr_ARTI_10613591
oai_doaj_org_article_5de4abda976d48ab88400d89fbf3df87
PMC11372095
39085350
10_1038_s12276_024_01281_4
Genre Journal Article
GeographicLocations Beijing China
United States--US
China
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GroupedDBID ---
0R~
29G
2WC
5-W
53G
5GY
7X7
87B
88E
8FE
8FH
8FI
8FJ
8JR
9ZL
AAJSJ
AASML
ABUWG
ACGFO
ACGFS
ACPRK
ACYCR
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
C1A
C6C
CCPQU
DIK
DU5
E3Z
EBLON
EBS
EF.
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
LK8
M1P
M7P
NAO
OK1
OVT
PHGZM
PHGZT
PIMPY
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
TR2
UKHRP
W2D
XSB
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PQEST
PQUKI
PRINS
PUEGO
7X8
5PM
ID FETCH-LOGICAL-c576t-18b6b5a3dbbd31dade1bf9d1f2bd60e18755b4a3f03a6d8f192ed2c4a3f31b933
IEDL.DBID DOA
ISSN 2092-6413
1226-3613
IngestDate Thu Jul 31 03:10:23 EDT 2025
Wed Aug 27 01:08:08 EDT 2025
Thu Aug 21 18:35:42 EDT 2025
Thu Jul 10 18:54:41 EDT 2025
Sat Aug 23 12:32:27 EDT 2025
Fri Jul 18 01:41:09 EDT 2025
Thu Jul 24 02:18:04 EDT 2025
Thu Apr 24 23:04:10 EDT 2025
Fri Jul 18 01:12:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c576t-18b6b5a3dbbd31dade1bf9d1f2bd60e18755b4a3f03a6d8f192ed2c4a3f31b933
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/5de4abda976d48ab88400d89fbf3df87
PMID 39085350
PQID 3100359734
PQPubID 2041975
PageCount 19
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10613591
doaj_primary_oai_doaj_org_article_5de4abda976d48ab88400d89fbf3df87
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11372095
proquest_miscellaneous_3086955559
proquest_journals_3100359734
pubmed_primary_39085350
crossref_primary_10_1038_s12276_024_01281_4
crossref_citationtrail_10_1038_s12276_024_01281_4
springer_journals_10_1038_s12276_024_01281_4
PublicationCentury 2000
PublicationDate 20240800
2024-08-01
2024-Aug
20240801
2024-08
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 8
  year: 2024
  text: 20240800
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: Seoul
PublicationTitle Experimental & molecular medicine
PublicationTitleAbbrev Exp Mol Med
PublicationTitleAlternate Exp Mol Med
PublicationYear 2024
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
생화학분자생물학회
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
– name: 생화학분자생물학회
References D Marlevi (1281_CR4) 2020; 10
S Lau (1281_CR34) 2021; 22
JK Lovett (1281_CR17) 2004; 110
R Arroyo (1281_CR19) 2019; 2
JY Wang (1281_CR11) 2007; 34
P Scapini (1281_CR23) 2014; 124
Y Doring (1281_CR8) 2017; 120
O Leavy (1281_CR24) 2015; 15
FD Sarno (1281_CR32) 2018; 1990
AJ Lusis (1281_CR2) 2000; 407
L Guo (1281_CR41) 2019; 104
CA Bursill (1281_CR37) 2010; 30
JP Parmar (1281_CR1) 2010; 122
X Jiang (1281_CR25) 2023; 157
S Divanovic (1281_CR26) 2005; 6
HJ Sung (1281_CR46) 2008; 40
C Van der Donckt (1281_CR36) 2015; 36
G Ostermann (1281_CR43) 2002; 3
RT Megens (1281_CR29) 2012; 107
PK Bhavsar (1281_CR38) 2008; 22
M Naghavi (1281_CR13) 2002; 164
J Xu (1281_CR44) 2008; 9
M Naghavi (1281_CR3) 2003; 108
SI Yoon (1281_CR28) 2010; 107
K Luo (1281_CR5) 2011; 32
C Acosta (1281_CR12) 2008; 86
E Kristóf (1281_CR45) 2013; 18
AV Finn (1281_CR31) 2010; 30
K Yuan (1281_CR16) 2020; 88
EA Osborn (1281_CR15) 2015; 30
K Miyake (1281_CR10) 1998; 161
1281_CR18
H Domev (1281_CR21) 2014; 3
DF Barber (1281_CR42) 2004; 173
OE Sørensen (1281_CR7) 2016; 126
C Zuchi (1281_CR20) 2020; 25
D Ribatti (1281_CR14) 2008; 40
T Quillard (1281_CR30) 2015; 36
U Ohto (1281_CR39) 2011; 413
S Wei (1281_CR40) 2010; 88
F Hayashi (1281_CR9) 2003; 102
A Osvaldova (1281_CR27) 2017; 114
JE Deanfield (1281_CR22) 2007; 115
L Barrientos (1281_CR6) 2014; 193
J Kalucka (1281_CR35) 2020; 180
K Sueishi (1281_CR33) 1997; 811
40670645 - Exp Mol Med. 2025 Jul 16. doi: 10.1038/s12276-025-01479-0.
References_xml – volume: 40
  start-page: 332
  year: 2008
  ident: 1281_CR46
  publication-title: Exp. Mol. Med.
  doi: 10.3858/emm.2008.40.3.332
– ident: 1281_CR18
  doi: 10.3791/52687
– volume: 107
  start-page: 597
  year: 2012
  ident: 1281_CR29
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH11-09-0650
– volume: 36
  start-page: 1049
  year: 2015
  ident: 1281_CR36
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehu041
– volume: 1990
  start-page: 020
  year: 2018
  ident: 1281_CR32
  publication-title: AIP Conf. Proc.
– volume: 18
  start-page: 1235
  year: 2013
  ident: 1281_CR45
  publication-title: Apoptosis
  doi: 10.1007/s10495-013-0873-z
– volume: 122
  start-page: 2031
  year: 2010
  ident: 1281_CR1
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.866053
– volume: 157
  start-page: 114000
  year: 2023
  ident: 1281_CR25
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2022.114000
– volume: 22
  start-page: 1807
  year: 2008
  ident: 1281_CR38
  publication-title: FASEB J.
  doi: 10.1096/fj.07-094235
– volume: 30
  start-page: 1282
  year: 2010
  ident: 1281_CR31
  publication-title: Arterioscler Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.108.179739
– volume: 30
  start-page: 1773
  year: 2010
  ident: 1281_CR37
  publication-title: Arterioscler Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.110.211342
– volume: 104
  start-page: 925
  year: 2019
  ident: 1281_CR41
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2019.03.004
– volume: 126
  start-page: 1612
  year: 2016
  ident: 1281_CR7
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI84538
– volume: 108
  start-page: 1664
  year: 2003
  ident: 1281_CR3
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000087480.94275.97
– volume: 22
  start-page: 978
  year: 2021
  ident: 1281_CR34
  publication-title: Int J. Mol. Sci.
  doi: 10.3390/ijms22020978
– volume: 10
  year: 2020
  ident: 1281_CR4
  publication-title: Sci. Rep.
– volume: 173
  start-page: 3653
  year: 2004
  ident: 1281_CR42
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.6.3653
– volume: 30
  start-page: 671
  year: 2015
  ident: 1281_CR15
  publication-title: Curr. Opin. Cardiol.
  doi: 10.1097/HCO.0000000000000226
– volume: 86
  start-page: 1077
  year: 2008
  ident: 1281_CR12
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.21565
– volume: 3
  start-page: 1169
  year: 2014
  ident: 1281_CR21
  publication-title: Stem Cells Transl. Med.
  doi: 10.5966/sctm.2014-0097
– volume: 193
  start-page: 5689
  year: 2014
  ident: 1281_CR6
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1400586
– volume: 161
  start-page: 1348
  year: 1998
  ident: 1281_CR10
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.161.3.1348
– volume: 34
  start-page: 407
  year: 2007
  ident: 1281_CR11
  publication-title: Int J. Immunogenet.
  doi: 10.1111/j.1744-313X.2007.00711.x
– volume: 36
  start-page: 1394
  year: 2015
  ident: 1281_CR30
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehv044
– volume: 25
  start-page: 21
  year: 2020
  ident: 1281_CR20
  publication-title: Heart Fail Rev.
  doi: 10.1007/s10741-019-09881-3
– volume: 15
  start-page: 526
  year: 2015
  ident: 1281_CR24
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3898
– volume: 32
  start-page: 7951
  year: 2011
  ident: 1281_CR5
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.07.006
– volume: 110
  start-page: 2190
  year: 2004
  ident: 1281_CR17
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000144307.82502.32
– volume: 88
  start-page: 495
  year: 2010
  ident: 1281_CR40
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1209822
– volume: 9
  start-page: 880
  year: 2008
  ident: 1281_CR44
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1628
– volume: 3
  start-page: 151
  year: 2002
  ident: 1281_CR43
  publication-title: Nat. Immunol.
  doi: 10.1038/ni755
– volume: 120
  start-page: 736
  year: 2017
  ident: 1281_CR8
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.116.309692
– volume: 40
  start-page: 606
  year: 2008
  ident: 1281_CR14
  publication-title: Ann. Med.
  doi: 10.1080/07853890802186913
– volume: 115
  start-page: 1285
  year: 2007
  ident: 1281_CR22
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.652859
– volume: 2
  start-page: 470
  year: 2019
  ident: 1281_CR19
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-019-0662-5
– volume: 164
  start-page: 27
  year: 2002
  ident: 1281_CR13
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(02)00018-7
– volume: 811
  start-page: 311
  year: 1997
  ident: 1281_CR33
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.1997.tb52011.x
– volume: 114
  start-page: 31
  year: 2017
  ident: 1281_CR27
  publication-title: Res Vet. Sci.
  doi: 10.1016/j.rvsc.2017.02.026
– volume: 407
  start-page: 233
  year: 2000
  ident: 1281_CR2
  publication-title: Nature
  doi: 10.1038/35025203
– volume: 413
  start-page: 815
  year: 2011
  ident: 1281_CR39
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2011.09.020
– volume: 102
  start-page: 2660e2669
  year: 2003
  ident: 1281_CR9
  publication-title: Blood
– volume: 88
  start-page: 106902
  year: 2020
  ident: 1281_CR16
  publication-title: Int Immunopharmacol.
  doi: 10.1016/j.intimp.2020.106902
– volume: 180
  start-page: 764
  year: 2020
  ident: 1281_CR35
  publication-title: Cell
  doi: 10.1016/j.cell.2020.01.015
– volume: 124
  start-page: 710
  year: 2014
  ident: 1281_CR23
  publication-title: Blood
  doi: 10.1182/blood-2014-03-453217
– volume: 6
  start-page: 571
  year: 2005
  ident: 1281_CR26
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1198
– volume: 107
  start-page: 10990
  year: 2010
  ident: 1281_CR28
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1004153107
– reference: 40670645 - Exp Mol Med. 2025 Jul 16. doi: 10.1038/s12276-025-01479-0.
SSID ssj0025474
Score 2.404732
Snippet The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of...
Abstract The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1717
SubjectTerms 13
14
38
631/114
631/250
631/337
631/80
Arteries
Arteriosclerosis
Artificial intelligence
Atherosclerosis
Bioinformatics
Biomedical and Life Sciences
Biomedicine
Cardiovascular disease
Cell activation
Cellular Microenvironment
Disease prevention
Endothelial cells
Extracellular Traps - metabolism
Female
Heart attacks
Heart diseases
Human Umbilical Vein Endothelial Cells - metabolism
Humans
Intercellular adhesion molecule 1
Leukocyte migration
Leukocytes (neutrophilic)
Macrophages
Male
Medical Biochemistry
Microenvironments
Molecular Medicine
Molecular modelling
Neutrophils
Neutrophils - immunology
Neutrophils - metabolism
NF-kappa B - metabolism
NF-κB protein
Plaque, Atherosclerotic - metabolism
Plaque, Atherosclerotic - pathology
Plaques
Signal Transduction
Stem Cells
Toll-like receptors
Umbilical vein
Vascularization
생화학
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgSIgLgo2PwEBGIC4QLa7txDmhgZgG0nZiUm-WHTtb1S4paXqAv573XCelfCxSlcqxJSfv2f69b0LelJyZTIgytSBPpFh4O1WVLVL4ZbXMK1syDE4-O89PL8TXqZxGhdsqulUOe2LYqF1boY78CBXRHNAvFx-W31OsGoXW1VhC4za5g6nL0KWrmG4FLilCFmYGECPlcG7FoJmMq6MVNBbofos-GBMFctTOwRTy98Nx03T1v6Dn3x6Uf5hRw-l08oDcj7CSHm_44CG55Zt9cnDcgEh9_YO-pcHRM2jQ98nds2hPPyA_z_2679rl1WxBYZfuDOrx0TGVwv_lioa4kt5TQIk0TBug-pxG3y66XBiYML1Gn77fAuaoaRxdI-y0CxhmurafuaHzGCz5iFycfP726TSN1RjSCmSSPmXK5lYa7qx1nDnjPLN16Vg9sS7PPAPBR1pheJ1xkztVA3T0blJhC2e25Pwx2Wvaxj8l1OSFsPDRs4k1wqDlLq9tJVXl86qQViWEDaTQVUxVjhUzFjqYzLnSG_JpIJ8O5NMiIe_GMctNoo4be39ECo89Mcl2aGi7Sx3XrJbOC2OdAcTmhDJWgTCcOVXWtuauVkVCXgN_6Hk1C-PxftnqeadBFPmiUdYGhmUJORz4R8f9YaW33JyQV-NjWNlIZtP4dg19QNosJVxlQp5s2G2cLy8BKnOZJUTtMOLOC-0-aWZXIXs4Y1iYqJQJeT_w7HZe__9iz25-jefk3iQsJnSNPCR7fbf2LwCu9fZlWJO_ANR-PXI
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Rb9QwDI7GkBAvCDZghYGCQLxARdMkbfI4JqaBtD0xaW9R0qTb6W7tqdd7gF-PnWsLBwOJSlWrxpHc2kns-rNDyBvNmc2E0KkDfyLFjbdTVbkyhTOrZVE5zTA5-ey8OL0QXy7l5Q7Jx1yYCNqPJS3jND2iwz6sWJ6XCJdFzESuwO-5Q-5i6XbU6uPieHKypCjFkByTcXVLv60FKNbph2Wl6erbTMw_kZK_hUvjKnTykDwYzEd6tGH4EdkJzR7ZP4J3aW--0bc0Ajrjn_I9cu9siJvvk-_nYd137fJ6tqAwG3cW_9cjAJXC_XJFY_5IHyhYgzSyDSb5nA4YLrpcWGCY3iB275fEOGobT9doXroFdLNd28_8SDwlRT4mFyefvh6fpsOuC2kFvkefMuUKJy33znnOvPWBuVp7VufOF1lg4OBIJyyvM24Lr2owEYPPK3zCmdOcPyG7TduEA0JtUQoHHz3LnRUWI3RF7SqpqlBUpXQqIWwUhamGkuS4M8bCxNA4V2YjPgPiM1F8RiTk3dRnuSnI8U_qjyjhiRKLaccHbXdlBuUy0gdhnbdgmXmhrFPg9GZe6drV3NeqTMhr0A8zr2axP16vWjPvDLgcnw361FxqlpDDUX_MMA-sDIZPoLHkwMmrqRlGMIrZNqFdAw14lVrCoRPydKNuE79cg0nMZZYQtaWIWy-03dLMrmOVcMZwAyItE_J-1NmffP39iz37P_Ln5H4eBxdCIg_Jbt-twwsw03r3Mo7LH5YQOVw
  priority: 102
  providerName: Springer Nature
Title Neutrophil extracellular traps mediate the crosstalk between plaque microenvironment and unstable carotid plaque formation
URI https://link.springer.com/article/10.1038/s12276-024-01281-4
https://www.ncbi.nlm.nih.gov/pubmed/39085350
https://www.proquest.com/docview/3100359734
https://www.proquest.com/docview/3086955559
https://pubmed.ncbi.nlm.nih.gov/PMC11372095
https://doaj.org/article/5de4abda976d48ab88400d89fbf3df87
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003114952
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Experimental and Molecular Medicine, 2024, 56(0), , pp.1717-1735
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgSIgXBBsfgVEZgXiBaHFsJ_ZjV20alVYhYFLfLDt2WNUuqdL0YfvrOTtpWfl8IVKUyh_S1XfO3S_3YYTeSkp0wpiMDeCJ2B-8HYvC5DHcScmzwkjik5PPJ9nZBRtP-fTWUV8-JqwrD9wt3BG3jmljNahNy4Q2AhBJYoUsTUltKUIeOei8DZjqoRZnOetTZBIqjlYkTXMfbOsjLlIBqGlHDYVq_aBcqqb8naH5a7zkT07ToItOH6GHvRGJhx3xj9EdV-2jg2EFAPrqGr_DIawzfC_fR_fPe-_5AbqZuHXb1MvL2QLDO7nR_qu9D0PF8Hu5wiGLpHUYbEIcyAbDfI77SC68XGggGF_5CL5b6XFYVxavvZFpFjBNN3U7s5vB29TIJ-ji9OTr6Czuz16IC0AgbUyEyQzX1BpjKbHaOmJKaUmZGpsljgDM4YZpWiZUZ1aUYCg6mxa-hRIjKX2K9qq6cs8R1lnODCx6khrNtPfTZaUpuChcVuTciAiRDStU0Rcm9-djLFRwkFOhOvYpYJ8K7FMsQu-3c5ZdWY6_jj72HN6O9CW1QwMImuoFTf1L0CL0BuRDzYtZmO-f32o1bxQAj4_KI2vKJYnQ4UZ-VP82WCnvRIHOnAIlr7fdsI89m3Xl6jWMAWwpOVwyQs86cdvSSyUYxpQnERI7grjzh3Z7qtllqBVOiD-GSPIIfdjI7A-6_rxiL_7Hir1ED9Kw5Xy45CHaa5u1ewUmXGsG6G4-zQfo3nA4_jKG5_HJ5NNnaB1lo0HYyd8BEwVKcw
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTgJeEGx8BAYY8fEC0eLYSZ0HhDbY1LK1QmiT9mbsONmqdklJW6HxR_E3cucmGeVjb6tUtUpsycmdz7-f785HyMuEMx0IkfgG-ISPhbd9mZquD98gj-LUJAyTkwfDuHcsPp1EJ2vkZ5MLg2GVjU10htqWKe6Rb-NGNAf0y8X76Tcfq0ahd7UpobFUi4Ps4jtQttm7_keQ76sw3N87-tDz66oCfgrYeu4zaWITaW6NsZxZbTNm8sSyPDQ2DjIGAD4yQvM84Dq2MgcIlNkwxSucmQQ3QMHkrwsOVKZD1nf3hp-_tBQvEu7cZwagxuewUtZpOgGX2zO42MWAX4z6CCUwt5Wl0FUMgAWuqPJ_gd2_Yzb_cNy69XD_DrldA1m6s9S8u2QtKzbI5k4BJP78gr6mLrTU7dlvkBuD2oO_SX4Ms8W8KqdnowmFdaHS6DnAUFgK_6cz6jJZ5hkFXErdsIEcjGkdTUanEw0DpucYRfhbih7VhaULBLpmAt10Vc5HtmncpmfeI8fXIqn7pFOURfaQUB13hYGXHoRGC42-wjg3aSTTLE67kZEeYY0oVFofjo41OibKOem5VEvxKRCfcuJTwiNv2j7T5dEgV7beRQm3LfFYb3ehrE5VbSVUZDOhjdWAEa2Q2kig34GVSW5ybnPZ9cgL0A81TkeuP_6elmpcKSA_fYXsHqYI88hWoz-qtkgzdTl_PPK8vQ22BMWsi6xcQBvgt0kEn8QjD5bq1o6XJwDOeRR4RK4o4soDrd4pRmfuvHLGsBRSEnnkbaOzl-P6_xt7dPVjPCM3e0eDQ3XYHx48JrdCN7EwMHOLdObVInsCYHFuntYzlJKv120UfgEpBn2N
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIU28INi4ZAww4vICUeM4TpwHhAaj2hireGBS34wdJ1vVLilpKjR-Gr-Oc9ykpVz2tkpVK8eWHJ_j4-_43Ah5nnKmgyhKfQP6hI-Ft32ZmcSHb1CIODMpw-Dkk0F8eBp9HIrhBvnZxcKgW2UnE52gtlWGd-Q9vIjmgH551Ctat4jPB_23028-VpBCS2tXTmPBIsf55XdQ32Zvjg6A1i_CsP_hy_tDv60w4GeAsxufSRMbobk1xnJmtc2ZKVLLitDYOMgZgHlhIs2LgOvYygLgUG7DDFs4MylehoL4v5FwwXCPJcOVsicilwGaAbzxOZyZbcBOwGVvBo0Juv6i_0coQYdbOxRd7QA46sq6-Bfs_dt78w8TrjsZ-7fJrRbS0v0FD94hG3m5TXb2S1DnLy7pS-qcTN3t_TbZOmlt-TvkxyCfN3U1PR9NKCxzrdGGgE6xFP5PZ9TFtDQ5BYRK3bRBTRjT1q-MTicaJkwv0J_wt2A9qktL5wh5zQSG6bpqRrbrvAzUvEtOr4VO98hmWZX5A0J1nEQGFj0IjY40Wg3jwmRCZnmcJcJIj7COFCpr06RjtY6JcuZ6LtWCfArIpxz5VOSRV8sx00WSkCt7v0MKL3tigm_XUNVnqpUXStg80sZqQIs2ktpIUMQDK9PCFNwWMvHIM-APNc5Gbjz-nlVqXCtQg44U6vmwWZhH9jr-Ua1smqnVTvLI0-VjkCpIZl3m1Rz6gKabCvikHrm_YLflfHkKMJ2LwCNyjRHXXmj9STk6d5nLGcOiSKnwyOuOZ1fz-v-K7V79Gk_IFogC9elocPyQ3AzdvkIPzT2y2dTz_BGgxsY8dtuTkq_XLQ9-AYkFgF0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophil+extracellular+traps+mediate+the+crosstalk+between+plaque+microenvironment+and+unstable+carotid+plaque+formation&rft.jtitle=Experimental+%26+molecular+medicine&rft.au=Cao%2C+Yu&rft.au=Chen%2C+Minghui&rft.au=Jiao%2C+Xinyu&rft.au=Li%2C+Shuijie&rft.date=2024-08-01&rft.issn=2092-6413&rft.eissn=2092-6413&rft.volume=56&rft.issue=8&rft.spage=1717&rft.epage=1735&rft_id=info:doi/10.1038%2Fs12276-024-01281-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s12276_024_01281_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-6413&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-6413&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-6413&client=summon